KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $10.4 billion.

  • Biogen's Total Non-Current Liabilities fell 157.34% to $10.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.4 billion, marking a year-over-year decrease of 157.34%. This contributed to the annual value of $10.4 billion for FY2025, which is 157.34% down from last year.
  • Per Biogen's latest filing, its Total Non-Current Liabilities stood at $10.4 billion for Q4 2025, which was down 157.34% from $10.2 billion recorded in Q3 2025.
  • In the past 5 years, Biogen's Total Non-Current Liabilities registered a high of $13.0 billion during Q3 2023, and its lowest value of $9.9 billion during Q1 2023.
  • In the last 5 years, Biogen's Total Non-Current Liabilities had a median value of $10.7 billion in 2022 and averaged $10.9 billion.
  • The largest annual percentage gain for Biogen's Total Non-Current Liabilities in the last 5 years was 1906.73% (2023), contrasted with its biggest fall of 1768.27% (2023).
  • Quarter analysis of 5 years shows Biogen's Total Non-Current Liabilities stood at $11.6 billion in 2021, then dropped by 11.86% to $10.2 billion in 2022, then grew by 10.2% to $11.3 billion in 2023, then decreased by 5.89% to $10.6 billion in 2024, then decreased by 1.57% to $10.4 billion in 2025.
  • Its Total Non-Current Liabilities stands at $10.4 billion for Q4 2025, versus $10.2 billion for Q3 2025 and $9.9 billion for Q2 2025.